Altshuler Shaham LTD United Therapeutics Corp Transaction History

Altshuler Shaham LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$212.99 - $276.17 $17,678 - $22,922	-83 Reduced 37.9%	136 $30,000
Q4 2022 May 09, 2023	SELL	$205.95 - $280.43 $10,709 - $14,582	-52 Reduced 19.19%	219 $60,000
Q3 2022 Nov 14, 2022	SELL	$203.3 - $244.17 $5,489 - $6,592	-27 Reduced 9.06%	271 $56,000
Q2 2022 Aug 10, 2022	BUY	$174.81 - $241.14 $13,460 - $18,567	77 Added 34.84%	298 $70,000
Q1 2022 May 16, 2022	BUY	$166.16 - $213.96 $36,721 - $47,285	221 New	221 $40,000
Q3 2021 Nov 15, 2021	SELL	$179.86 - $214.88 $112,052 - $133,870	-623 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$170.47 - $211.93 $852 - $1,059	5 Added 0.81%	623 $112,000
Q1 2021 May 13, 2021	BUY	$153.94 - $174.85 $52,031 - $59,099	338 Added 120.71%	618 $103,000
Q4 2020 Feb 16, 2021	BUY	$101.87 - $151.79 $3,667 - $5,464	36 Added 14.75%	280 $43,000
Q3 2020 Nov 10, 2020	SELL	$99.9 - $121.13 $15,684 - $19,017	-157 Reduced 39.15%	244 $25,000
Q2 2020 Aug 13, 2020	BUY	$92.74 - $125.82 $9,366 - $12,707	101 Added 33.67%	401 $49,000
Q1 2020 May 12, 2020	BUY	$79.39 - $115.35 $23,817 - $34,605	300 New	300 $28,000

668

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.